LeonaBio, Inc. (LONA) — Strategic Asset Allocation Index
LeonaBio, Inc. (LONA) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $130.19 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check LONA cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
LeonaBio, Inc. Strategic Asset Allocation Index (2021–2023)
This chart shows how LeonaBio, Inc.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $130.19 Million USD. See LeonaBio, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for LeonaBio, Inc. (2021–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for LeonaBio, Inc. from 2021 to 2023, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see LeonaBio, Inc. (LONA) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $130.19 Million | ▼ -19.1 pp |
| 2022 | 19.1% | $44.83 Million | $- | $44.83 Million | $235.14 Million | ▼ -1.5 pp |
| 2021 | 20.5% | $65.94 Million | $- | $65.94 Million | $321.08 Million | — |